All fact checks
AI analysis
Fact check
“The Food and Drug Administration (FDA) is describing the approaches it is considering for the design of early‑phase clinical trials of ibogaine drug products.”
UnverifiableConfidence: LOW
Reasoning
The claim states that the FDA is describing approaches for early-phase clinical trials of ibogaine drug products, but without any documents or sources, there is no basis to verify the statement.
On confidence: No supplied evidence was provided to confirm or refute the claim.
Evidence
No retrievable evidence was found; the verdict rests on the reporting itself and is marked accordingly.
Limitations
Evaluation is limited to the absence of any supplied evidence; external information was not consulted.
- Last verified:
- Oct 6, 2026, 4:16 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for InformationFederal Register · Drug Administration, Human Services Department, Food, Health